Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07421843

Short Interval Versus Long Interval Repeated Extracorporeal Shockwave Lithotripsy (ESWL) for 8-15 mm Renal Stones.

Double Extracorporeal Shockwave Lithotripsy for Renal Stones.

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
600 (estimated)
Sponsor
Region Skane · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Extracorporeal shockwave lithotripsy (ESWL) is one way to treat renal stones. In this clinical trial our goal is to evaluate if two ESWL the same week is equal good and safe to two ESWL 3 weeks regarding renal stones 8-15 mm.

Detailed description

All patients with a renal stone 8-15 mm are asked to participate. If they give consent they are randomized to ESWL with an interval of 2 days or 3 weeks. Data regarding age, gender, stone size, Hounsfield unit, skin to stone distance, urine culture, results from the follow up CT and need for auxillary interventions are extraced from the medical records.

Conditions

Interventions

TypeNameDescription
PROCEDUREExtracorporeal shockwave lithotripsy (ESWL)ESWL, two treatments with an interval of two days or three weeks.

Timeline

Start date
2022-10-04
Primary completion
2026-04-01
Completion
2026-04-01
First posted
2026-02-19
Last updated
2026-02-19

Locations

2 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT07421843. Inclusion in this directory is not an endorsement.

Short Interval Versus Long Interval Repeated Extracorporeal Shockwave Lithotripsy (ESWL) for 8-15 mm Renal Stones. (NCT07421843) · Clinical Trials Directory